nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—CBR1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0598	0.0598	CbGpPWpGaD
Haloperidol—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0327	0.0327	CbGpPWpGaD
Haloperidol—H1F0—Apoptosis—BCL2L11—sclerosing cholangitis	0.0302	0.0302	CbGpPWpGaD
Haloperidol—HTR1D—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0291	0.0291	CbGpPWpGaD
Haloperidol—HTR1B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0285	0.0285	CbGpPWpGaD
Haloperidol—DRD4—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.028	0.028	CbGpPWpGaD
Haloperidol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0274	0.0274	CbGpPWpGaD
Haloperidol—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0269	0.0269	CbGpPWpGaD
Haloperidol—HTR2B—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0267	0.0267	CbGpPWpGaD
Haloperidol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0256	0.0256	CbGpPWpGaD
Haloperidol—CBR1—NRF2 pathway—GGT1—sclerosing cholangitis	0.0254	0.0254	CbGpPWpGaD
Haloperidol—DRD1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0252	0.0252	CbGpPWpGaD
Haloperidol—DRD3—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0249	0.0249	CbGpPWpGaD
Haloperidol—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.0237	0.0237	CbGpPWpGaD
Haloperidol—UGT1A9—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0233	0.0233	CbGpPWpGaD
Haloperidol—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.0228	0.0228	CbGpPWpGaD
Haloperidol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0219	0.0219	CbGpPWpGaD
Haloperidol—EBP—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0212	0.0212	CbGpPWpGaD
Haloperidol—CBR1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0208	0.0208	CbGpPWpGaD
Haloperidol—GRIN2B—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.0199	0.0199	CbGpPWpGaD
Haloperidol—DRD2—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.019	0.019	CbGpPWpGaD
Haloperidol—HTR2A—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0187	0.0187	CbGpPWpGaD
Haloperidol—HRH1—GPCRs, Class A Rhodopsin-like—GPR35—sclerosing cholangitis	0.0187	0.0187	CbGpPWpGaD
Haloperidol—GRIN2B—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.0175	0.0175	CbGpPWpGaD
Haloperidol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0169	0.0169	CbGpPWpGaD
Haloperidol—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.0157	0.0157	CbGpPWpGaD
Haloperidol—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.0143	0.0143	CbGpPWpGaD
Haloperidol—CYP1A1—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.0134	0.0134	CbGpPWpGaD
Haloperidol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.0131	0.0131	CbGpPWpGaD
Haloperidol—UGT1A9—Phase II conjugation—GGT1—sclerosing cholangitis	0.0114	0.0114	CbGpPWpGaD
Haloperidol—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.011	0.011	CbGpPWpGaD
Haloperidol—CYP1A1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0103	0.0103	CbGpPWpGaD
Haloperidol—EBP—Metabolism—ABCB4—sclerosing cholangitis	0.00943	0.00943	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—ABCB4—sclerosing cholangitis	0.00928	0.00928	CbGpPWpGaD
Haloperidol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00904	0.00904	CbGpPWpGaD
Haloperidol—EBP—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00868	0.00868	CbGpPWpGaD
Haloperidol—CBR1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00854	0.00854	CbGpPWpGaD
Haloperidol—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00845	0.00845	CbGpPWpGaD
Haloperidol—H1F0—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00839	0.00839	CbGpPWpGaD
Haloperidol—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.0077	0.0077	CbGpPWpGaD
Haloperidol—UGT1A9—NRF2 pathway—GGT1—sclerosing cholangitis	0.00763	0.00763	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00732	0.00732	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—TCF4—sclerosing cholangitis	0.00712	0.00712	CbGpPWpGaD
Haloperidol—KCNH2—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00677	0.00677	CbGpPWpGaD
Haloperidol—UGT1A9—Biological oxidations—GGT1—sclerosing cholangitis	0.00669	0.00669	CbGpPWpGaD
Haloperidol—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00658	0.00658	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00627	0.00627	CbGpPWpGaD
Haloperidol—CYP3A7—Biological oxidations—GGT1—sclerosing cholangitis	0.00563	0.00563	CbGpPWpGaD
Haloperidol—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.0046	0.0046	CbGpPWpGaD
Haloperidol—EBP—Metabolism—GOT2—sclerosing cholangitis	0.00448	0.00448	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—GOT2—sclerosing cholangitis	0.00441	0.00441	CbGpPWpGaD
Haloperidol—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.00419	0.00419	CbGpPWpGaD
Haloperidol—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00418	0.00418	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00408	0.00408	CbGpPWpGaD
Haloperidol—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.00407	0.00407	CbGpPWpGaD
Haloperidol—EBP—Metabolism—GGT1—sclerosing cholangitis	0.00387	0.00387	CbGpPWpGaD
Haloperidol—EBP—Metabolism—GOT1—sclerosing cholangitis	0.00387	0.00387	CbGpPWpGaD
Haloperidol—CYP1A1—Biological oxidations—GGT1—sclerosing cholangitis	0.00384	0.00384	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—GGT1—sclerosing cholangitis	0.0038	0.0038	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—GOT1—sclerosing cholangitis	0.0038	0.0038	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—HIF1A—sclerosing cholangitis	0.00367	0.00367	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00367	0.00367	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00362	0.00362	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.0036	0.0036	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00342	0.00342	CbGpPWpGaD
Haloperidol—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.00314	0.00314	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00294	0.00294	CbGpPWpGaD
Haloperidol—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.00289	0.00289	CbGpPWpGaD
Haloperidol—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.00287	0.00287	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—ABCB4—sclerosing cholangitis	0.00279	0.00279	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.00277	0.00277	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00269	0.00269	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00257	0.00257	CbGpPWpGaD
Haloperidol—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.00245	0.00245	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—ABCB4—sclerosing cholangitis	0.00235	0.00235	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00229	0.00229	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.00189	0.00189	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00177	0.00177	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00173	0.00173	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00171	0.00171	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.0017	0.0017	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00163	0.00163	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—ABCB4—sclerosing cholangitis	0.0016	0.0016	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00154	0.00154	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00152	0.00152	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00148	0.00148	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GOT2—sclerosing cholangitis	0.00133	0.00133	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.00131	0.00131	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.00128	0.00128	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.00121	0.00121	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.00121	0.00121	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.0012	0.0012	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00116	0.00116	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GGT1—sclerosing cholangitis	0.00114	0.00114	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—GOT1—sclerosing cholangitis	0.00114	0.00114	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00114	0.00114	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.00114	0.00114	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GOT2—sclerosing cholangitis	0.00111	0.00111	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.0011	0.0011	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.00102	0.00102	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GOT1—sclerosing cholangitis	0.000962	0.000962	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—GGT1—sclerosing cholangitis	0.000962	0.000962	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000941	0.000941	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	0.000806	0.000806	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000789	0.000789	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GOT2—sclerosing cholangitis	0.000761	0.000761	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000753	0.000753	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000738	0.000738	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000726	0.000726	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	0.000696	0.000696	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	0.000696	0.000696	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000693	0.000693	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GOT1—sclerosing cholangitis	0.000657	0.000657	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—GGT1—sclerosing cholangitis	0.000657	0.000657	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000653	0.000653	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000645	0.000645	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	0.000623	0.000623	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000608	0.000608	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000573	0.000573	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000568	0.000568	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	0.000538	0.000538	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	0.000538	0.000538	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000525	0.000525	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000525	0.000525	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	0.000495	0.000495	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	0.000495	0.000495	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000493	0.000493	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	0.00049	0.00049	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	0.00049	0.00049	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.000485	0.000485	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000485	0.000485	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000484	0.000484	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	0.000419	0.000419	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	0.000419	0.000419	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000375	0.000375	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	0.000323	0.000323	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	0.000323	0.000323	CbGpPWpGaD
